Ben Jones, vice president of Government Relations and Public Policy at the US Oncology Network, discussed the Enhancing Oncology Model (EOM), and why it's such an important topic at this year's conference.
True collaboration among the Center for Medicare and Medicaid Innovation (CMMI), physicians, and practices is possible for the Enhancing Oncology Model (EOM), believes Ben Jones, vice president of Government Relations and Public Policy at the US Oncology Network.
Jones presented on federal legislative updates at the Community Oncology Conference hosted by the Community Oncology Alliance (COA).
Transcript
What do you think are the most compelling issues covered at this year’s COA conference?
There's been a lot of themes at this year's conference, more so than any other year that I remember. There's a lot of conversations about PBM [pharmacy benefit manager] and payer mandates that are impacting the ability for practices to take control of the total cost of care.
Everyone is talking about bending the cost curve; everyone is talking about the value-based care approach. But at the same time, they're layering in these mandates that are really handcuffing practices, through patient steerage, white bagging mandates, prior authorization that is excessively delaying care. And it's all of these kind of mandates that are disrupting the practices ability to deliver the care in a timely way that they see fit, which is the most efficient manner that they see fit.
A major topic of discussion at this year’s conference surrounds the EOM. What are the major concerns from US Oncology physicians and practices that you are sharing with CMMI?
The US Oncology Network has been a leader in the Oncology Care Model [OCM]. We take value-based care very seriously. We wanted to be on the forefront, and we were regularly engaged with CMMI to ensure that any value-based care model actually had positive impact not only for the practices, but the patients we serve. And we think that that goal was actually accomplished in the OCM.
We were excited to see the next iteration rollout in the Enhancing Oncology Model. However, there are a couple of factors that we think need to be addressed. I mean, at a very high level, without going into too much detail, you can summarize the EOM fairly simply by saying they want you to do more and they're going to pay you less. That's not always a great recipe for success. Now, they think that they've gotten the MEOS—these Monthly Enhanced Oncology Service payments—they think they've right sized them a little bit lower, but at the same time, they're asking the practices to do a lot more. Whether that's through ePROs [electronic patient-reported outcomes], whether that's through SDOH [social determinant of health] reporting, all of that cost more money at the same time that they're reducing the MEOS payment.
Now, do we think that we've got the perfect answer? Probably needs to have kind of a little bit of a back-and-forth on what [CMMI] truly wants, what data they're willing to provide us to make it easier to comply with some of these new regulations, and then we can figure out what the appropriate payment structure looks like. But at the end of the day, it's not a great recipe for success to have a model that pays you less to do more.
We are optimistic, though. And one thing I will note about CMMI, is they have been a terrific partner in engaging in these conversations. This is not a message that's new. And it's also not one that's often easy to hear. But the folks at CMMI have been terrific at least engaging in that back-and-forth conversation. So, we're hopeful that as the EOM comes as enrollment starts, we do get that kind of back and forth, that true collaboration with CMMI as a partner to make sure it's a successful model.
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More